Clinical Trials Browser

Phase 1/2 × veledimex × 1 year × Clear all

NCT02423902 2025-08-28

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer

Phase 1/2 Terminated

9 enrolled 21 charts

Breast Neoplasms